Stellate Ganglion Block for the Management of Cannabis Use Disorder: A Case Series. [PDF]
Charan N, Karanth V, Niraj S, Niraj G.
europepmc +1 more source
Abstract Background and Aims Oral nicotine pouches (NPs) are a new class of non‐combustible nicotine products that have gained rapid popularity. Despite rising sales and marketing, evidence of their prevalence and risk perceptions remains limited. This systematic review aimed to synthesize the available global evidence on the prevalence and patterns of
Salma Mahmoodianfard +7 more
wiley +1 more source
Genetic Pathways Point to the Biology Underlying the Association Between Cannabis Use Disorder and Psychosis. [PDF]
Austin-Zimmerman I +15 more
europepmc +1 more source
Cannabis consumer responses to the concept of standard THC units
Abstract Aims Within a context of considerable cannabis market expansion and product diversification, cannabis consumers must manage their use across a range of potencies and modes of consumption. This study aimed to provide deeper understandings of how cannabis consumers would perceive the introduction of a standard THC (tetrahydrocannabinol) unit ...
Mark Pawson, Mike Vuolo, Brian C. Kelly
wiley +1 more source
The Association Between Cannabis Use and Electrocardiographic Abnormalities in People Living With HIV. [PDF]
Larson ME +27 more
europepmc +1 more source
Abstract Background and aims Cannabis cue reactivity paradigms are instrumental in studying the behavioral and neurocognitive mechanisms of cannabis use and cannabis use disorders; however, image sets used for cannabis cue reactivity paradigms vary between studies, and the lack of reliability and validity assessment hinders the quality of evidence they
Janna Cousijn +6 more
wiley +1 more source
Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics. [PDF]
Basedow LA +4 more
europepmc +1 more source
Beyond abstinence: Redefining success in cannabis use disorder treatment
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin +3 more
wiley +1 more source
Associations between neighborhood disadvantage, cannabis use, and patient-reported outcomes among patients with cancer. [PDF]
Greene B +5 more
europepmc +1 more source
Testing the robustness of daily associations of affect with alcohol and cannabis use. [PDF]
Dora J +10 more
europepmc +1 more source

